ENZYMBI
Samsung Bioepis Co., Ltd.
Mark For: ENZYMBI™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88318089 |
| Mark Literal Elements | ENZYMBI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 128 - EXAMINING ATTORNEY ASSIGNED 2019-03-29 |
| Basis | 1(b) 44(d) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Stephen R. Barrese, Esq. |
| Attorney Docket Number | 587-962 |
| Law Office Assigned | O10 |
| Employee Name | AURAND, MEGAN LEE |
Timeline
| 2019-02-27 | Application Filed |
| 2019-03-29 | Location: TMO LAW OFFICE 128 - EXAMINING ATTORNEY ASSIGNED |
| 2019-06-03 | Abandon |
| 2019-06-04 | Status: Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Documen |
| 2019-06-04 | Status: Dead/Abandoned |
| 2019-06-04 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Samsung Bioepis Co., Ltd. |
| Address | 107, Cheomdan-daero, Yeonsu-gu, Incheon, KOREA, REPUBLIC OF 21987 |
| Legal Entity Type | Limited Company |
| Legal Entity State | KOREA, REPUBLIC OF |
Documents
 Drawing | JPEG | 2019-02-27 |
 TEAS RF New Application | MULTI | 2019-02-27 |
| XSearch Search Summary | XML | 2019-03-26 |
| Examiners Amendment | XML | 2019-03-29 |
| Notation to File | XML | 2019-03-29 |
| Suspension Letter | XML | 2019-03-29 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-03-30 |
| Express Abandonment | XML | 2019-06-03 |
| Notice of Abandonment | APPLICATION/XML | 2019-06-04 |
Attorney of Record
Good, Services, and Codes
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | 2019-06-04 | |
| ABANDONMENT - EXPRESS MAILED | 2019-06-04 | |
| TEAS EXPRESS ABANDONMENT RECEIVED | 2019-06-03 | |
| SUSPENSION LETTER WRITTEN | 2019-03-29 | 94476 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-03-29 | 6332 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-03-29 | 6328 |
| LETTER OF SUSPENSION E-MAILED | 2019-03-29 | 6332 |
| EXAMINERS AMENDMENT E-MAILED | 2019-03-29 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2019-03-29 | 94476 |
| EXAMINER'S AMENDMENT ENTERED | 2019-03-29 | 88888 |
| ASSIGNED TO EXAMINER | 2019-03-26 | 94476 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-19 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-03-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 